FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/01/101474 [Registered on: 19/01/2026] Trial Registered Prospectively
Last Modified On: 17/01/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A study comparing two local anesthetic skin treatments to reduce pain during IV cannulation in patients undergoing planned surgery. 
Scientific Title of Study   A comparative study of the effectiveness of lidocaine patch and EMLA cream on peripheral intravenous cannulation pain in patients posted for elective surgeries. 
Trial Acronym  NA 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Pradeep Kumar Yadav 
Designation  Junior Resident 
Affiliation  Subharti Medical College 
Address  Department of Anaesthesiology & Critical Care, Subharti Medical College,NH-58,Delhi-Haridwar Bypass Road, Subhartipuram, Meerut
Department of Anaesthesiology & Critical Care, Subharti Medical College,NH-58,Delhi-Haridwar Bypass Road, Subhartipuram, Meerut
Meerut
UTTAR PRADESH
250005
India 
Phone  7705969160  
Fax    
Email  ypradeepkumar922@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Brig HS Minhas 
Designation  Professor 
Affiliation  Subharti Medical College 
Address  Department of Anaesthesiology & Critical Care, Subharti Medical College,NH-58,Delhi-Haridwar Bypass Road, Subhartipuram, Meerut

Meerut
UTTAR PRADESH
250005
India 
Phone  9950797341  
Fax    
Email  hsminhas28@yahoo.co.in  
 
Details of Contact Person
Public Query
 
Name  Dr Brig HS Minhas 
Designation  Professor 
Affiliation  Subharti Medical College 
Address  Department of Anaesthesiology & Critical Care, Subharti Medical College,NH-58,Delhi-Haridwar Bypass Road, Subhartipuram, Meerut

Meerut
UTTAR PRADESH
250005
India 
Phone  9950797341  
Fax    
Email  hsminhas28@yahoo.co.in  
 
Source of Monetary or Material Support  
Chhatrapati Shivaji Subharti Hospital, Subharti Medical College, Meerut, Uttar Pradesh, 250005 (India) 
 
Primary Sponsor  
Name  NIL 
Address  NIL 
Type of Sponsor  Other [] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Pradeep Kumar Yadav  Chhatrapati Shivaji Subharti Hospital  Chhatrapati Shivaji Subharti Hospital, Subharti Medical College, NH-58, Delhi-Haridwar Bypass Road, Subhartipuram, Meerut
Meerut
UTTAR PRADESH 
7705969160

ypradeepkumar922@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
University Ethics Committee (Medical)  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  EMLA cream  Prilocaine 2.5% and 2.5% Lidocaine. EMLA cream will be applied 30 minutes before peripheral iv cannulation. 
Intervention  Lidocaine patch 5%  Patch will be applied 30 minutes before peripheral iv cannulation. 
 
Inclusion Criteria  
Age From  12.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1. Patients aged between 12 to 60 years.
2. Both male and female patients.
3. Patients scheduled for elective surgeries requiring iv cannulation.
 
 
ExclusionCriteria 
Details  1. History of any cardiac disease (arrhythmia), vascualr disease.
2. Presence of local skin infection.
3. Use of analgesics within 24 hours prior to cannulation.
Known allergy or sensitivity to amide local anaesthetic or glycerine.
 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
The primary outcome will be the pain score during peripheral intravenous cannulation, measured using a Visual Analog Scale (VAS) of 0-10  Immediately & 1 minute after cannulation. 
 
Secondary Outcome  
Outcome  TimePoints 
Changes in hemodynamic parameters during intravenous cannulation, Incidence and severity of local skin reactions following application of lidocaine patch or EMLA cream.  2 years 
 
Target Sample Size   Total Sample Size="78"
Sample Size from India="78" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   30/01/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This is a prospective, randomized comparative study which compares the effectiveness of lidocaine patch and EMLA cream on peripheral intravenous cannulation pain in patients posted for elective surgeries. The primary objective is to compare the effectiveness of EMLA cream versus lidocaine patch. The secondary objective is to observe any hemodynamic changes during iv cannulation and to assess any local skin reaction to EMLA cream or lidocaine patch. 
Close